ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 48 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $21,000 | -36.4% | 123,669 | 0.0% | 0.00% | – |
Q2 2022 | $33,000 | -52.2% | 123,669 | 0.0% | 0.00% | – |
Q1 2022 | $69,000 | -21.6% | 123,669 | -0.6% | 0.00% | – |
Q4 2021 | $88,000 | -56.4% | 124,369 | 0.0% | 0.00% | – |
Q3 2021 | $202,000 | -26.0% | 124,369 | -9.1% | 0.00% | – |
Q2 2021 | $273,000 | -71.9% | 136,872 | -53.2% | 0.00% | – |
Q1 2021 | $970,000 | -24.3% | 292,217 | -9.3% | 0.00% | – |
Q4 2020 | $1,282,000 | +50.1% | 322,099 | -0.8% | 0.00% | – |
Q3 2020 | $854,000 | -17.4% | 324,857 | -4.9% | 0.00% | – |
Q2 2020 | $1,034,000 | +67.0% | 341,460 | +8.1% | 0.00% | – |
Q1 2020 | $619,000 | -70.9% | 315,904 | +9.4% | 0.00% | – |
Q4 2019 | $2,125,000 | +61.0% | 288,731 | -1.1% | 0.00% | – |
Q3 2019 | $1,320,000 | -55.9% | 291,931 | -2.8% | 0.00% | -100.0% |
Q2 2019 | $2,993,000 | -10.7% | 300,197 | +4.6% | 0.00% | 0.0% |
Q1 2019 | $3,353,000 | -0.8% | 287,081 | +2.0% | 0.00% | 0.0% |
Q4 2018 | $3,381,000 | -29.6% | 281,534 | -0.2% | 0.00% | 0.0% |
Q3 2018 | $4,805,000 | +269.9% | 281,981 | +270.6% | 0.00% | – |
Q2 2018 | $1,299,000 | – | 76,088 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|